Crystacare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 10.00 K
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 125.31%
- Profit Growth -4.65%
- Ebitda -653.27%
- Net Worth -42.84%
- Total Assets -29.55%
About Crystacare Lifesciences
Crystacare Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 December 2020 (Four years and two months 14 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Amresh Pandey and Akhileshwar Pandey serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33119BR2020PTC049463
-
Company No.
049463
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Dec 2020
-
Date of AGM
30 Aug 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Crystacare Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amresh Pandey
|
Director | 02-Dec-2020 | Current |
|
Akhileshwar Pandey
|
Director | 02-Dec-2020 | Current |
Financial Performance of Crystacare Lifesciences.
Crystacare Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 125.31% increase. The company also saw a slight decrease in profitability, with a 4.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crystacare Lifesciences?
Unlock access to Crystacare Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Coredrug Private LimitedAmresh Pandey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crystacare Lifesciences?
Crystacare Lifesciences has a workforce of 0 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crystacare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crystacare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.